.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Accenture
Moodys
Citi
Queensland Health
Johnson and Johnson
US Department of Justice
McKinsey
Deloitte
Teva

Generated: June 25, 2017

DrugPatentWatch Database Preview

KAON CL Drug Profile

« Back to Dashboard

What is the patent landscape for Kaon Cl, and when can generic versions of Kaon Cl launch?

Kaon Cl is a drug marketed by Savage Labs and is included in one NDA.

The generic ingredient in KAON CL is potassium chloride. There are two hundred and twenty-seven drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.

Summary for Tradename: KAON CL

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list127
Patent Applications: see list203
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KAON CL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Savage Labs
KAON CL
potassium chloride
TABLET, EXTENDED RELEASE;ORAL017046-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Savage Labs
KAON CL-10
potassium chloride
TABLET, EXTENDED RELEASE;ORAL017046-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
AstraZeneca
Colorcon
Accenture
Medtronic
Mallinckrodt
Julphar
Federal Trade Commission
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot